No Prescription |
 |
 | ||
|
Lexapro Generic Escitalopram |
|
| ||
No Prescription » Prescription Drugs 10 » Lexapro Generic Escitalopram Escitalopram is an antidepressant (selective serotonin reuptake inhibitor-SSRI) used to treat depression and anxiety. It works by restoring the balance of certain natural substances (neurotransmitters such as serotonin) in the brain. Escitalopram may improve your feelings of well-being and energy level and decrease nervousness.How to use Lexapro OralRead the Medication Guide provided by your pharmacist before you start using escitalopram and each time you get a refill. If you have any questions consult your doctor or pharmacist.Take this medication once daily in the morning or evening with or without food or as directed by your doctor. The dosage is based on your medical condition and response to treatment. If you are using the liquid form of this medication measure the dose carefully using a special measuring device/spoon. Do not use a household spoon because you may not get the correct dose.To reduce your risk of side effects your doctor may Online you to start taking this drug at a low dose and gradually increase your dose. Follow your doctor's instructions carefully. Do not take more or less medication or take it more frequently than prescribed. Your condition will not improve any faster and your risk of side effects will increase. Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same time each day.It is important to continue taking this medication even if you feel well. Do not stop taking this medication without consulting your doctor. Some conditions may become worse when the drug is suddenly stopped. Your dose may need to be gradually decreased.This medication may cause dependence especially if it has been used regularly for an extended time or if it has been used in high doses. In such cases withdrawal reactions (e.g. nervousness headache numbness tingling trouble sleeping confusion) may occur if you suddenly stop this drug. To prevent withdrawal when stopping extended/regular treatment with this drug gradually reduce the dosage as directed. Consult your doctor or pharmacist for more details and report any withdrawal reactions immediately.It may take 1 to 2 weeks to feel a benefit from this drug and 4 weeks to feel the full benefit of this medication. Tell your doctor if your condition persists or worsens. Buy Lexapro Generic Escitalopram and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About Lexapro Generic Escitalopram: Product Type: Prescription Drugs 10 Lexapro ( Generic Escitalopram ) Lexapro (Generic Escitalopram) Generic Escitalopram 10mg Generic Escitalopram Lexapro
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
